Quantitative Chemotherapeutic Profiling of Gynecologic Cancer Cell Lines Using Approved Drugs and Bioactive Compounds1

Heterogeneous response to chemotherapy is a major issue for the treatment of cancer. For most gynecologic cancers including ovarian, cervical, and placental, the list of available small molecule therapies is relatively small compared to options for other cancers. While overall cancer mortality rates...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Translational oncology 2018-12, Vol.12 (3), p.441-452
Hauptverfasser:	Gorshkov, Kirill, Sima, Ni, Sun, Wei, Lu, Billy, Huang, Wei, Travers, Jameson, Klumpp-Thomas, Carleen, Michael, Samuel G., Xu, Tuan, Huang, Ruili, Lee, Emily M., Cheng, Xiaodong, Zheng, Wei
Format:	Artikel
Sprache:	eng
Schlagworte:	Original article
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!